Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion type Assertion NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_head.
- NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion wasGeneratedBy ECO_0000203 NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_provenance.
- NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion wasDerivedFrom befree-20140225 NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_provenance.
- NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion SIO_000772 20470425 NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_provenance.
- NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion evidence source_evidence_literature NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_provenance.
- NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_assertion description "[These results further suggest that CSB represents a potential target for cancer therapy that may be important to overcome resistance to cisplatin in the clinic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174415.RAKgvwFSL3VuFsymzeWvZ5I3Pybx3XWG1JA1NZKpHbhvM130_provenance.